» Articles » PMID: 25372103

Syndromes of Thrombotic Microangiopathy

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2014 Nov 6
PMID 25372103
Citations 52
Authors
Affiliations
Soon will be listed here.
Citing Articles

Early administration of caplacizumab combined with plasma exchange for thrombotic microangiopathy due to malignant hypertension: a case report.

Okawa H, Wada Y, Takeuchi K, Motohashi T, Abe T, Uchitsubo R CEN Case Rep. 2025; .

PMID: 40029564 DOI: 10.1007/s13730-025-00978-3.


Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: A Single-Center Experience.

Malgaj Vrecko M, Ales-Rigler A, Borstnar S, Veceric-Haler Z Int J Mol Sci. 2024; 25(22).

PMID: 39596538 PMC: 11594656. DOI: 10.3390/ijms252212475.


Clinical Characteristics and Treatment Courses of Trauma-Induced Thrombotic Microangiopathy: A Retrospective Study.

Hwang S, Kim G, Cho S, Lim K J Clin Med. 2024; 13(21).

PMID: 39518668 PMC: 11547120. DOI: 10.3390/jcm13216527.


Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies.

Urra M, Lyons S, Teodosiu C, Burwick R, Java A Kidney Int Rep. 2024; 9(8):2353-2371.

PMID: 39156177 PMC: 11328568. DOI: 10.1016/j.ekir.2024.05.016.


Effect of COVID-19 on Thrombosis Incidence and Patient Prognosis in Kidney Transplant Recipients.

Jiang H, Cao Z, Liu L, Huang Y Med Sci Monit. 2024; 30:e944285.

PMID: 38946121 PMC: 11305100. DOI: 10.12659/MSM.944285.